Cargando…

Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study

Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulskas, Audrius, Gaizauskas, Vytautas, Kildusiene, Inga, Samalavicius, Narimantas Evaldas, Smailyte, Giedre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765021/
https://www.ncbi.nlm.nih.gov/pubmed/33327538
http://dx.doi.org/10.3390/jcm9124038
_version_ 1783628393797910528
author Dulskas, Audrius
Gaizauskas, Vytautas
Kildusiene, Inga
Samalavicius, Narimantas Evaldas
Smailyte, Giedre
author_facet Dulskas, Audrius
Gaizauskas, Vytautas
Kildusiene, Inga
Samalavicius, Narimantas Evaldas
Smailyte, Giedre
author_sort Dulskas, Audrius
collection PubMed
description Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included. We examined the changes in colorectal cancer mortality and survival rates between 1998 and 2012 according to cancer anatomical sub-sites and stages. We calculated the 5-year relative survival estimates using period analysis. Results: Overall, 20,980 colorectal cancer cases reported from 1998 to 2012 were included in the study. The total number of newly diagnosed colorectal cancers increased from 1998–2002 to 2008–2012 by 12.1%. The highest number of colorectal cancers was localized and increased from 33.9% to 42.0%. The number of cancers with regional metastases and advanced cancers decreased by 11.1% and 15.5%, respectively. An increased number of new cases was observed for almost all colon cancer sub-sites. The overall 5-year relative survival rate increased from 37.9% in 1998–2002 to 51.5% in 2008–2012. We showed an increase in survival rates for all stages and all sub-sites. In the most recent period, patients with a localized disease had a 5-year survival rate of 78.6%, while survival estimates for advanced cancer patients remained low at 6.6%. Conclusion: Although survival rates variated in colorectal cancer patients according to disease stages and sub-sites, we showed increased survival rates for all patients.
format Online
Article
Text
id pubmed-7765021
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77650212020-12-27 Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study Dulskas, Audrius Gaizauskas, Vytautas Kildusiene, Inga Samalavicius, Narimantas Evaldas Smailyte, Giedre J Clin Med Article Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included. We examined the changes in colorectal cancer mortality and survival rates between 1998 and 2012 according to cancer anatomical sub-sites and stages. We calculated the 5-year relative survival estimates using period analysis. Results: Overall, 20,980 colorectal cancer cases reported from 1998 to 2012 were included in the study. The total number of newly diagnosed colorectal cancers increased from 1998–2002 to 2008–2012 by 12.1%. The highest number of colorectal cancers was localized and increased from 33.9% to 42.0%. The number of cancers with regional metastases and advanced cancers decreased by 11.1% and 15.5%, respectively. An increased number of new cases was observed for almost all colon cancer sub-sites. The overall 5-year relative survival rate increased from 37.9% in 1998–2002 to 51.5% in 2008–2012. We showed an increase in survival rates for all stages and all sub-sites. In the most recent period, patients with a localized disease had a 5-year survival rate of 78.6%, while survival estimates for advanced cancer patients remained low at 6.6%. Conclusion: Although survival rates variated in colorectal cancer patients according to disease stages and sub-sites, we showed increased survival rates for all patients. MDPI 2020-12-14 /pmc/articles/PMC7765021/ /pubmed/33327538 http://dx.doi.org/10.3390/jcm9124038 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dulskas, Audrius
Gaizauskas, Vytautas
Kildusiene, Inga
Samalavicius, Narimantas Evaldas
Smailyte, Giedre
Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title_full Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title_fullStr Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title_full_unstemmed Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title_short Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study
title_sort improvement of survival over time for colorectal cancer patients: a population-based study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765021/
https://www.ncbi.nlm.nih.gov/pubmed/33327538
http://dx.doi.org/10.3390/jcm9124038
work_keys_str_mv AT dulskasaudrius improvementofsurvivalovertimeforcolorectalcancerpatientsapopulationbasedstudy
AT gaizauskasvytautas improvementofsurvivalovertimeforcolorectalcancerpatientsapopulationbasedstudy
AT kildusieneinga improvementofsurvivalovertimeforcolorectalcancerpatientsapopulationbasedstudy
AT samalaviciusnarimantasevaldas improvementofsurvivalovertimeforcolorectalcancerpatientsapopulationbasedstudy
AT smailytegiedre improvementofsurvivalovertimeforcolorectalcancerpatientsapopulationbasedstudy